<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药通社 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-12T12:03:39+08:00</updated>
  <subtitle>医药：政策、资讯、产业、发展</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>突发，风向变了！药品集采，严禁低于成本报价竞标，否则纳入失信！！</title>
    <updated>2021-01-12T09:14:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/QMQ49sq9TmipLWbNetrU0w</id>
    <link href="https://mp.weixin.qq.com/s/QMQ49sq9TmipLWbNetrU0w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NMPA 1月12日，多款注射剂通一致性，2家艾司奥美拉唑钠</title>
    <updated>2021-01-12T09:14:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/gRnbAHCPveaESWc4uTiEsw</id>
    <link href="https://mp.weixin.qq.com/s/gRnbAHCPveaESWc4uTiEsw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2021-01-12T09:14:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/HXq9xM_y5Fapci0UfLpIyw</id>
    <link href="https://mp.weixin.qq.com/s/HXq9xM_y5Fapci0UfLpIyw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ED药物战国纷争，他达拉非片，近30个厂家，约60个受理，近10家获批，还有机会吗？</title>
    <updated>2021-01-11T11:23:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/Q3lXAG7ecdy7AHXzh4DdxA</id>
    <link href="https://mp.weixin.qq.com/s/Q3lXAG7ecdy7AHXzh4DdxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最新！恒瑞等3药企，7个药品受理纳入优先审评公示！</title>
    <updated>2021-01-11T11:23:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/ZWSqh3WWMldAXQWICc1sAA</id>
    <link href="https://mp.weixin.qq.com/s/ZWSqh3WWMldAXQWICc1sAA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《国家药品监督管理局关于促进中药传承创新发展的实施意见》政策解读</title>
    <updated>2021-01-11T11:23:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/YCu2l3J-vb1WwGr8mZVujA</id>
    <link href="https://mp.weixin.qq.com/s/YCu2l3J-vb1WwGr8mZVujA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2021-01-11T11:23:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/zbz1xAK5qdg1Ofr6KdiDqA</id>
    <link href="https://mp.weixin.qq.com/s/zbz1xAK5qdg1Ofr6KdiDqA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>我国创新药专利期限补偿计算方式探讨</title>
    <updated>2021-01-10T21:44:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/LXIyoSEcAF3oQJ-2-x3sig</id>
    <link href="https://mp.weixin.qq.com/s/LXIyoSEcAF3oQJ-2-x3sig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NMPA公开征求《牙膏备案资料规范》意见</title>
    <updated>2021-01-10T21:44:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/QJZtCZXKR-n4R8QW53OKLw</id>
    <link href="https://mp.weixin.qq.com/s/QJZtCZXKR-n4R8QW53OKLw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【产业观察】以为小适应症，结果TRK新药大热门</title>
    <updated>2021-01-10T21:44:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/KuruDDmoOoNLKIm0rZv5Vg</id>
    <link href="https://mp.weixin.qq.com/s/KuruDDmoOoNLKIm0rZv5Vg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2021-01-10T21:44:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/cJpJ6YH6PH2CJrymyRTPJQ</id>
    <link href="https://mp.weixin.qq.com/s/cJpJ6YH6PH2CJrymyRTPJQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>齐鲁制药：共计49个产品通过一致性评价</title>
    <updated>2021-01-09T21:54:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/ccsXSKfGgWto_S5m4Y7z3Q</id>
    <link href="https://mp.weixin.qq.com/s/ccsXSKfGgWto_S5m4Y7z3Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>宜昌人福药业：累计15个品种通过一致性评价</title>
    <updated>2021-01-09T21:54:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/jcnu-OA19pUd_0SjaybhVg</id>
    <link href="https://mp.weixin.qq.com/s/jcnu-OA19pUd_0SjaybhVg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠疫苗全民免费接种！医保基金和财政共同负担</title>
    <updated>2021-01-09T21:54:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/VW334WH5eocvrImhdEhOoQ</id>
    <link href="https://mp.weixin.qq.com/s/VW334WH5eocvrImhdEhOoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2021-01-09T21:54:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/87K_8Xi80jiIUmXl8VvIeQ</id>
    <link href="https://mp.weixin.qq.com/s/87K_8Xi80jiIUmXl8VvIeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE《化学药品注射剂灭菌和无菌工艺研究及验证指导原则（试行）》</title>
    <updated>2021-01-08T19:49:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/BCSun3xh3r9fyaMmR2oEvQ</id>
    <link href="https://mp.weixin.qq.com/s/BCSun3xh3r9fyaMmR2oEvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DOE试验设计在湿法制粒工艺优化中的应用</title>
    <updated>2021-01-08T19:49:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/IQihfmyxZsX8PYoYi0eGTA</id>
    <link href="https://mp.weixin.qq.com/s/IQihfmyxZsX8PYoYi0eGTA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2021-01-08T19:49:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/lh9YAD1X0l2PtKu8OTw2ug</id>
    <link href="https://mp.weixin.qq.com/s/lh9YAD1X0l2PtKu8OTw2ug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>6000亿恒瑞，全球研发总部项目在张江开工</title>
    <updated>2021-01-07T09:09:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/5dt9EvZ-mbspSUTwLCBSXw</id>
    <link href="https://mp.weixin.qq.com/s/5dt9EvZ-mbspSUTwLCBSXw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NMPA发文：一大批注射剂通过一致性评价！6药企、7产品、18品规！</title>
    <updated>2021-01-07T09:09:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/6_sNIEh-tT66wripC4gYkQ</id>
    <link href="https://mp.weixin.qq.com/s/6_sNIEh-tT66wripC4gYkQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>